Lazard Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-30	Closed	–	–	2531
2024 Q4	$0	Hold	30	–	–	﹤0.01%	2491
2024 Q3	$0	Sell	30 -48	-62%	-$983	﹤0.01%	2423
2024 Q2	$1K	Sell	78 -1,076	-93%	-$24.7K	﹤0.01%	2173
2024 Q1	$30K	Sell	1,154 -640	-36%	-$18.2K	﹤0.01%	1805
2023 Q4	$52K	Buy	1,794 +72	+4%	+$1.59K	﹤0.01%	1880
2023 Q3	$34K	Buy	1,722 +79	+5%	+$1.44K	﹤0.01%	1970
2023 Q2	$32K	Buy	1,643 +45	+3%	+$909	﹤0.01%	1971
2023 Q1	$26K	Buy	1,598 +320	+25%	+$6.27K	﹤0.01%	1991
2022 Q4	$24K	Sell	1,278 -360	-22%	-$6.63K	﹤0.01%	2104
2022 Q3	$25K	Buy	1,638 +5	+0.3%	+$78	﹤0.01%	2032
2022 Q2	$21K	Buy	1,633 +67	+4%	+$799	﹤0.01%	2124
2022 Q1	$24K	Buy	1,566 +430	+38%	+$7.43K	﹤0.01%	2029
2021 Q4	$24K	Buy	1,136 +195	+21%	+$5.32K	﹤0.01%	2015
2021 Q3	$27K	Sell	941 -463	-33%	-$16.9K	﹤0.01%	1933
2021 Q2	$61K	Buy	1,404 +1,354	+2,708%	+$58.8K	﹤0.01%	1515
2021 Q1	$2K	Hold	50	–	–	﹤0.01%	1811
2020 Q4	$2K	Buy	+50	New	+$1.82K	﹤0.01%	1810
2018 Q4	–	Sell	-69,681	Closed	-$1.72M	–	1073
2018 Q3	$1.72M	Buy	+69,681	New	+$1.51M	﹤0.01%	677